HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy
Abstract Cancer immunotherapies based mainly on the blockade of immune-checkpoint (IC) molecules by anti-IC antibodies offer new alternatives for treatment in oncological diseases. However, a considerable proportion of patients remain unresponsive to them. Hence, the development of novel clinical im...
Saved in:
Main Authors: | María Belén Palma, Diana Tronik-Le Roux, Guadalupe Amín, Sheila Castañeda, Alan M. Möbbs, María Agustina Scarafia, Alejandro La Greca, Marina Daouya, Isabelle Poras, Ana María Inda, Lucía N. Moro, Edgardo D. Carosella, Marcela N. García, Santiago G. Miriuka |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/894a26ff5d8c49e7b84811e2e58054c0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
celldeath: A tool for detection of cell death in transmitted light microscopy images by deep learning-based visual recognition.
by: Alejandro Damián La Greca, et al.
Published: (2021) -
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
by: K. G. Paulson, et al.
Published: (2018) -
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
by: Geok Wee Tan, et al.
Published: (2021) -
Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT
by: C. E. Aban, et al.
Published: (2021) -
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
by: Peilong Li, et al.
Published: (2021)